Skip to main content

Ascension Asset Management LLC

SEC CIK
0001714062
Latest filing
Aug 16, 2024

EW holding history

Edwards Lifesciences Corp in every 13F filed by Ascension Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2024 holdings

Shares (Q2 2024)
16,650
Value
$1.54M
% of portfolio
0.8%
Quarters held
10
Since Q1 2021
Holdings of EW by Ascension Asset Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202416,650$1.54M0.8%−1,275−7.1%ReducedHolders
Q1 202417,925$1.71M0.9%–No prior filingHolders
Q3 2023––––Not filedHolders
Q2 202317,800$1.68M1.0%–No prior filingHolders
Q1 2023––––Not filedHolders
Q4 202217,950$1.34M1.0%00.0%UnchangedHolders
Q3 202217,950$1.48M1.2%00.0%UnchangedHolders
Q2 202217,950$1.71M1.3%–No prior filingHolders
Q1 2022––––Not filedHolders
Q4 202118,330$2.38M1.4%−105−0.6%ReducedHolders
Q3 202118,435$2.09M1.4%00.0%UnchangedHolders
Q2 202118,435$1.91M1.2%−75−0.4%ReducedHolders
Q1 202118,510$1.55M1.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.